4c0u › Citations

Neutralizing antibodies can initiate genome release from human enterovirus 71.

Plevka P, Lim PY, Perera R, Cardosa J, Suksatu A, Kuhn RJ, Rossmann MG
Proc Natl Acad Sci U S A 111 2134-9 (2014)
Related entries: 4c0y, 4c10

Cited: 46 times
EuropePMC logo PMID: 24469789

Abstract

Antibodies were prepared by immunizing mice with empty, immature particles of human enterovirus 71 (EV71), a picornavirus that causes severe neurological disease in young children. The capsid structure of these empty particles is different from that of the mature virus and is similar to "A" particles encountered when picornaviruses recognize a potential host cell before genome release. The monoclonal antibody E18, generated by this immunization, induced a conformational change when incubated at temperatures between 4 °C and 37 °C with mature virus, transforming infectious virions into A particles. The resultant loss of genome that was observed by cryo-EM and a fluorescent SYBR Green dye assay inactivated the virus, establishing the mechanism by which the virus is inactivated and demonstrating that the E18 antibody has potential as an anti-EV71 therapy. The antibody-mediated virus neutralization by the induction of genome release has not been previously demonstrated. Furthermore, the present results indicate that antibodies with genome-release activity could also be produced for other picornaviruses by immunization with immature particles.

Articles - 4c0u mentioned but not cited (4)

  1. Neutralizing antibodies can initiate genome release from human enterovirus 71. Plevka P, Lim PY, Perera R, Cardosa J, Suksatu A, Kuhn RJ, Rossmann MG. Proc Natl Acad Sci U S A 111 2134-2139 (2014)
  2. Improved metrics for comparing structures of macromolecular assemblies determined by 3D electron-microscopy. Joseph AP, Lagerstedt I, Patwardhan A, Topf M, Winn M. J Struct Biol 199 12-26 (2017)
  3. Crystal structure of the fibre head domain of the Atadenovirus Snake Adenovirus 1. Singh AK, Menéndez-Conejero R, San Martín C, van Raaij MJ. PLoS One 9 e114373 (2014)
  4. Serotype specific epitopes identified by neutralizing antibodies underpin immunogenic differences in Enterovirus B. Wang K, Zheng B, Zhang L, Cui L, Su X, Zhang Q, Guo Z, Guo Y, Zhang W, Zhu L, Zhu F, Rao Z, Wang X. Nat Commun 11 4419 (2020)


Reviews citing this publication (9)

  1. Update on enterovirus 71 infection. Huang PN, Shih SR. Curr Opin Virol 5 98-104 (2014)
  2. Immunopathogenesis and Virus-Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease. Cox JA, Hiscox JA, Solomon T, Ooi MH, Ng LFP. Front Microbiol 8 2249 (2017)
  3. Viral entry pathways: the example of common cold viruses. Blaas D. Wien Med Wochenschr 166 211-226 (2016)
  4. Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease. Fang CY, Liu CC. Expert Rev Vaccines 17 819-831 (2018)
  5. Evolutionary and Structural Overview of Human Picornavirus Capsid Antibody Evasion. Cifuente JO, Moratorio G. Front Cell Infect Microbiol 9 283 (2019)
  6. Cryo-EM Studies of Virus-Antibody Immune Complexes. Li N, Li Z, Fu Y, Cao S. Virol Sin 35 1-13 (2020)
  7. From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD). He X, Zhang M, Zhao C, Zheng P, Zhang X, Xu J. Virol Sin 36 167-175 (2021)
  8. Functional assessment and structural basis of antibody binding to human papillomavirus capsid. Zhang X, Li S, Modis Y, Li Z, Zhang J, Xia N, Zhao Q. Rev Med Virol 26 115-128 (2016)
  9. Mechanisms of Rhinovirus Neutralisation by Antibodies. Touabi L, Aflatouni F, McLean GR. Viruses 13 360 (2021)

Articles citing this publication (33)

  1. Structure of tick-borne encephalitis virus and its neutralization by a monoclonal antibody. Füzik T, Formanová P, Růžek D, Yoshii K, Niedrig M, Plevka P. Nat Commun 9 436 (2018)
  2. Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody. Xu L, Zheng Q, Li S, He M, Wu Y, Li Y, Zhu R, Yu H, Hong Q, Jiang J, Li Z, Li S, Zhao H, Yang L, Hou W, Wang W, Ye X, Zhang J, Baker TS, Cheng T, Zhou ZH, Yan X, Xia N. Nat Commun 8 505 (2017)
  3. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity. Ren J, Wang X, Zhu L, Hu Z, Gao Q, Yang P, Li X, Wang J, Shen X, Fry EE, Rao Z, Stuart DI. J Virol 89 10500-10511 (2015)
  4. Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody. Ye X, Fan C, Ku Z, Zuo T, Kong L, Zhang C, Shi J, Liu Q, Chen T, Zhang Y, Jiang W, Zhang L, Huang Z, Cong Y. PLoS Pathog 12 e1005454 (2016)
  5. Antibody-induced uncoating of human rhinovirus B14. Dong Y, Liu Y, Jiang W, Smith TJ, Xu Z, Rossmann MG. Proc Natl Acad Sci U S A 114 8017-8022 (2017)
  6. Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization. Zheng Q, Zhu R, Xu L, He M, Yan X, Liu D, Yin Z, Wu Y, Li Y, Yang L, Hou W, Li S, Li Z, Chen Z, Li Z, Yu H, Gu Y, Zhang J, Baker TS, Zhou ZH, Graham BS, Cheng T, Li S, Xia N. Nat Microbiol 4 124-133 (2019)
  7. Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site. Wang X, Zhu L, Dang M, Hu Z, Gao Q, Yuan S, Sun Y, Zhang B, Ren J, Kotecha A, Walter TS, Wang J, Fry EE, Stuart DI, Rao Z. Proc Natl Acad Sci U S A 114 770-775 (2017)
  8. Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral Entry. Ku Z, Ye X, Shi J, Wang X, Liu Q, Huang Z. J Virol 89 12084-12095 (2015)
  9. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Arthur Huang KY, Chen MF, Huang YC, Shih SR, Chiu CH, Lin JJ, Wang JR, Tsao KC, Lin TY. Nat Commun 8 762 (2017)
  10. Structures of Coxsackievirus A10 unveil the molecular mechanisms of receptor binding and viral uncoating. Zhu L, Sun Y, Fan J, Zhu B, Cao L, Gao Q, Zhang Y, Liu H, Rao Z, Wang X. Nat Commun 9 4985 (2018)
  11. Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71. Zhu L, Xu K, Wang N, Cao L, Wu J, Gao Q, Fry EE, Stuart DI, Rao Z, Wang J, Wang X. mBio 9 e01013-18 (2018)
  12. Structural Basis of Human Parechovirus Neutralization by Human Monoclonal Antibodies. Shakeel S, Westerhuis BM, Ora A, Koen G, Bakker AQ, Claassen Y, Wagner K, Beaumont T, Wolthers KC, Butcher SJ. J Virol 89 9571-9580 (2015)
  13. The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro. Shingler KL, Cifuente JO, Ashley RE, Makhov AM, Conway JF, Hafenstein S. J Virol 89 1900-1908 (2015)
  14. Cryo-Electron Microscopy Structure of Seneca Valley Virus Procapsid. Strauss M, Jayawardena N, Sun E, Easingwood RA, Burga LN, Bostina M. J Virol 92 e01927-17 (2018)
  15. Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16. He M, Xu L, Zheng Q, Zhu R, Yin Z, Zha Z, Lin Y, Yang L, Huang Y, Ye X, Li S, Hou W, Wu Y, Han J, Liu D, Li Z, Chen Z, Yu H, Que Y, Wang Y, Yan X, Zhang J, Gu Y, Zhou ZH, Cheng T, Li S, Xia N. Cell Host Microbe 27 249-261.e5 (2020)
  16. Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10. Zhu R, Xu L, Zheng Q, Cui Y, Li S, He M, Yin Z, Liu D, Li S, Li Z, Chen Z, Yu H, Que Y, Liu C, Kong Z, Zhang J, Baker TS, Yan X, Hong Zhou Z, Cheng T, Xia N. Sci Adv 4 eaat7459 (2018)
  17. Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity. Jia Q, Ng Q, Chin W, Meng T, Chow VTK, Wang CI, Kwang J, He F. Sci Rep 7 46402 (2017)
  18. Neutralization Mechanism of a Monoclonal Antibody Targeting a Porcine Circovirus Type 2 Cap Protein Conformational Epitope. Huang L, Sun Z, Xia D, Wei Y, Sun E, Liu C, Zhu H, Bian H, Wu H, Feng L, Wang J, Liu C. J Virol 94 e01836-19 (2020)
  19. Human Antibodies to VP4 Inhibit Replication of Enteroviruses Across Subgenotypes and Serotypes, and Enhance Host Innate Immunity. Phanthong S, Densumite J, Seesuay W, Thanongsaksrikul J, Teimoori S, Sookrung N, Poovorawan Y, Onvimala N, Guntapong R, Pattanapanyasat K, Chaicumpa W. Front Microbiol 11 562768 (2020)
  20. Structural basis for neutralization of hepatitis A virus informs a rational design of highly potent inhibitors. Cao L, Liu P, Yang P, Gao Q, Li H, Sun Y, Zhu L, Lin J, Su D, Rao Z, Wang X. PLoS Biol 17 e3000229 (2019)
  21. Viral neutralization by antibody-imposed physical disruption. Zheng Q, Jiang J, He M, Zheng Z, Yu H, Li T, Xue W, Tang Z, Ying D, Li Z, Song S, Liu X, Wang K, Zhang Z, Wang D, Wang Y, Yan X, Zhao Q, Zhang J, Gu Y, Li S, Xia N. Proc Natl Acad Sci U S A 116 26933-26940 (2019)
  22. Functional and structural characterization of a two-MAb cocktail for delayed treatment of enterovirus D68 infections. Zhang C, Xu C, Dai W, Wang Y, Liu Z, Zhang X, Wang X, Wang H, Gong S, Cong Y, Huang Z. Nat Commun 12 2904 (2021)
  23. Structures of Foot-and-Mouth Disease Virus with Bovine Neutralizing Antibodies Reveal the Determinant of Intraserotype Cross-Neutralization. He Y, Li K, Wang L, Sun Z, Cao Y, Li P, Sun P, Bao H, Zhou S, Wang S, Bai X, Liu X, Zhao L, Fan X, Liu Z, Lu Z, Yang C, Lou Z. J Virol 95 e0130821 (2021)
  24. Antiviral Activity of a Llama-Derived Single-Domain Antibody against Enterovirus A71. Huang PN, Wang HC, Hung HC, Tseng SN, Chang TY, Chou MY, Chen YJ, Wang YM, Shih SR, Hsu JT. Antimicrob Agents Chemother 64 e01922-19 (2020)
  25. Bioinformatics-based prediction of conformational epitopes for Enterovirus A71 and Coxsackievirus A16. Wang L, Zhu M, Fang Y, Rong H, Gao L, Liao Q, Zhang L, Dong C. Sci Rep 11 5701 (2021)
  26. Structural and functional analysis of protective antibodies targeting the threefold plateau of enterovirus 71. Huang KA, Zhou D, Fry EE, Kotecha A, Huang PN, Yang SL, Tsao KC, Huang YC, Lin TY, Ren J, Stuart DI. Nat Commun 11 5253 (2020)
  27. Albumin Enhances the Rate at Which Coxsackievirus B3 Strain 28 Converts to A-Particles. Carson SD, Cole AJ. J Virol 94 e01962-19 (2020)
  28. Identification of specific and shared epitopes at the extreme N-terminal VP1 of Coxsackievirus A4, A2 and A5 by monoclonal antibodies. Tian YX, Jin WP, Wei ZN, Lv SY, Wang MJ, Meng SL, Guo J, Wang ZJ, Shen S. Virus Res 328 199074 (2023)
  29. Computational and Rational Design of Single-Chain Antibody against Tick-Borne Encephalitis Virus for Modifying Its Specificity. Baykov IK, Desyukevich PY, Mikhaylova EE, Kurchenko OM, Tikunova NV. Viruses 13 1494 (2021)
  30. Non-neutralizing monoclonal antibody targeting VP2 EF loop of Coxsackievirus A16 can protect mice from lethal attack via Fc-dependent effector mechanism. Du R, An C, Yao X, Wang Y, Wang G, Gao F, Bian L, Hu Y, Liu S, Zhao Q, Mao Q, Liang Z. Emerg Microbes Infect 12 2149352 (2023)
  31. Introductory Journal Article Editorial overview: emerging viruses. Basler CF, Woo PC. Curr Opin Virol 5 v-vii (2014)
  32. Engineering a novel IgG-like bispecific antibody against enterovirus A71. Wang HC, Hung HC, Huang PN, Kung YA, Tseng SN, Wang YM, Shih SR, Tsu-An Hsu J. Biochem Biophys Rep 24 100860 (2020)
  33. Letter Reverse Genetic Analysis of Adaptive Mutations within the Capsid Proteins of Enterovirus 71 (EV-A71) Strains Necessary for Infection of CHO-K1 Cells. Victorio CBL, Xu Y, Ng Q, Chow VTK, Chua KB. Virol Sin 35 110-114 (2020)


Quick links